Zevra Therapeutics Inc — Quarterly Cash Flow (NASDAQ:ZVRA) | MetaTrader

Open full chart

Financials

Overview Relatórios Statistics Dividends

Quarterly Annual

Total assets 191.55 M178.13 M172.71 M256.28 M270.12 M Total liabilities 121.78 M138.46 M131.69 M139.05 M136.95 M Total equity 69.77 M39.67 M41.02 M117.23 M133.16 M Total liabilities & shareholders' equities 191.55 M178.13 M172.71 M256.28 M270.12 M Total debt ————— Net debt —————

Notícias

Aclaris Therapeutics (ACRS) Reports Q4 Loss, Lags Revenue Estimates

Ironwood Pharmaceuticals (IRWD) Reports Q4 Loss, Lags Revenue Estimates

Neil F. McFarlane, presidente da Zevra Therapeutics, vende ações no valor de US$ 125 mil

Neil F. McFarlane, Zevra Therapeutics president, sells $125k in shares

Joshua Schafer, CCO da Zevra, vende ações da ZVRA no valor de US$ 29.800

Diretor médico da Zevra Therapeutics vende ações no valor de US$ 40 mil

Zevra Therapeutics CMO Quartel sells $40k in shares

Schafer Joshua, CCO of Zevra, sells $29,800 in ZVRA stock

CEO da Zevra Therapeutics, McFarlane, vende ações no valor de US$ 853 mil

Zevra Therapeutics CEO McFarlane sells $853k in shares

Zevra Therapeutics, Inc. (ZVRA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Zevra Stock: Asymmetric Risk-Reward Setup In Ultra-Rare Disease Market (ZVRA)